HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

The association of metabolic syndrome and COVID-19 deterioration

Abstract : Background and aims To evaluate the prevalence and prognostic value of metabolic syndrome (MetS) in patients admitted for coronavirus disease 2019 (COVID-19). Methods and results In this monocentric cohort retrospective study, we consecutively included all adult patients admitted to COVID-19 units between April 9 and May 29, 2020 and between February 1 and March 26, 2021. MetS was defined when at least three of the following components were met: android obesity, high HbA1c, hypertension, hypertriglyceridemia, and low HDL cholesterol. COVID-19 deterioration was defined as the need for nasal oxygen flow ≥6 L/min within 28 days after admission. We included 155 patients (55.5% men, mean age 61.7 years old, mean body mass index 29.8 kg/m2). Fifty-six patients (36.1%) had COVID-19 deterioration. MetS was present in 126 patients (81.3%) and was associated with COVID-19 deterioration (no-MetS vs MetS: 13.7% and 41.2%, respectively, p < 0.01). Logistic regression taking into account MetS, age, gender, ethnicity, period of inclusion, and Charlson Index showed that COVID-19 deterioration was 5.3 times more likely in MetS patients (95% confidence interval 1.3–20.2) than no-MetS patients. Conclusions Over 81.3% of patients hospitalized in COVID-19 units had MetS. This syndrome appears to be an independent risk factor of COVID-19 deterioration.
Complete list of metadata

Contributor : Marie-Liesse Bertram Connect in order to contact the contributor
Submitted on : Monday, March 28, 2022 - 9:52:50 AM
Last modification on : Thursday, April 7, 2022 - 1:58:16 PM

Links full text



Elise Ouedraogo, Lucie Allard, Hélène Bihan, Jeanne Goupil de Bouillé, Bénédicte Giroux-Leprieur, et al.. The association of metabolic syndrome and COVID-19 deterioration. Nutrition, Metabolism and Cardiovascular Diseases, Elsevier, 2021, 31 (11), pp.3236-3242. ⟨10.1016/j.numecd.2021.08.036⟩. ⟨hal-03621240⟩



Record views